Table 1. Characteristics of advanced stage (III, IVA & IVB) hypopharyngeal cancer.

*ChemoRT = definitive chemoradiation therapy; RT = radiation therapy

	All Patients	Definitive ChemoRT	Surgery	p-value
	(n = 103)	n = 72 (69.9%)	n = 31 (30.1%)
Age, Mean (SD)	60.3 (9.3)	59.7 (9.5)	61.2 (8.8)	0.508
Gender/ Sex
Male	92 (89.3%)	64 (89.9%)	28 (90.3%)	0.829
Female	11 (10.7%)	8 (11.1%)	3 (9.7%)
Ethnicity
Caucasians	39 (37.9%)	28 (38.9%)	11 (35.5%)	0.945
African Americans	61 (59.2%)	42 (58.3%)	19 (61.3%
Others	3 (2.9%)	2 (2.8%)	1 (3.2%)
Smoking status				0.035
Smoker	80 (77.7%)	60 (83.3%)	20 (64.5%)
Non-Smoker	23 (22.3%)	12 (16.7%)	11 (35.5%)
Alcohol Status				0.98
Drinker	60 (58.3%)	42 (58.3%)	18 (58.1%)
Non- Drinker	43 (41.7%)	30 (41.7%)	13 (41.9%)
TNM Stage (III, IV)
T classification				0.024
T1	8 (7.8%)	5 (6.9%)	3 (9.7%)
T2	13 (12.6%)	12 (16.7%)	1 (3.2%)
T3	17 (16.5%)	8 (11.1%)	9 (29.0%)
T4	41 (39.8%)	33 (45.8%)	8 (25.8%)
Unknown	24 (23.3%)	14 (19.4%)	10 (32.3%)
N Classification				0.116
N0	20 (19.4%)	12 (16.7%)	8 (25.8%)
N1	8 (7.8%)	7 (9.7%)	1 (3.2%)
N2	45 (43.7%)	34 (47.2%)	11 (35.5%)
N3	9 (8.7%)	8 (11.1%)	1 (3.2%)
Unknown	21 (20.4%)	11 (15.3%)	10 (32.3%)
Sub-site				0.057
Pyriform Sinus	75 (72.8%)	51 (70.8%)	24 (77.4%)
Post-pharyngeal Wall	10 (9.7%)	10 (13.9%)	0 (0.0%)
Post-Cricoid	5 (4.9%)	3 (4.2%)	2 (6.5%)
Hypopharynx Unknown	13 (12.3%)	8 (11.2 %)	5 (16.1 %)